Ambrx Biopharma Inc. Total Liabilities and Equity
Ambrx Biopharma Inc. had Total Liabilities and Equity of $279.94 million as of 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2023-08-09
- 2023-06-30: Liabilities and Equity $279.94M.
- 2023-03-31: Liabilities and Equity $210.61M.
- 2022-12-31: Liabilities and Equity $146.98M.
- 2022-06-30: Liabilities and Equity $180.87M.
| Period end | Liabilities and Equity |
|---|---|
| 2023-06-30 | $279.94M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $210.61M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $146.98M 10-Q · filed 2023-08-09 |
| 2022-06-30 | $180.87M 6-K · filed 2022-08-29 |
| 2021-12-31 | $229.02M 10-K · filed 2023-03-30 |
| 2020-12-31 | $134.02M 20-F · filed 2022-04-26 |